BioLineRx Ltd.
BioLineRx Enters into $5.6 Million Royalty Monetization Transaction with Soleus Capital
- Transaction provides non-dilutive capital through sale of BioLineRx's portion of future APHEXDA royalties - - Funds to support clinical development…
